EVIO Inc. (EVIO) Expanding into Biosciences with a Focus on Cannabis and Cannabinoid Research
EVIO Biosciences Division will research and develop new medical cannabis therapies New division will be headed by the company’s chief science officer, Dr. Anthony Smith EVIO CEO and co-founder to present at key microcap investor conference As an established leader in cannabis testing in the United States and Canada, EVIO Inc. (OTCQB: EVIO) is more familiar than most with the knowns and unknowns of medical cannabis. The company is now maximizing its technical know-how and experience by expanding into the research and development of cannabis-based medicines. In a press release issued on May 24, EVIO unveiled the launch of its…